What is CorMedix's total equity?

CorMedix (CRMD) reported total equity of $437.05M in Q1 2026.

How has CorMedix's total equity changed year-over-year?

CorMedix's total equity increased by 280.4% year-over-year, from $114.89M to $437.05M.

What is the long-term trend for CorMedix's total equity?

Over 5 years (2020 to 2025), CorMedix's total equity has grown at a 55.7% compound annual growth rate (CAGR), from $44.22M to $405.31M.

What does total equity mean?

Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

CorMedix CRMD Total Equity

Total Equity at other companies

PfizerPFE

$90.1B-0.3%

Merck & Co.MRK

$45.88B-5.1%

Merit Medical SystemsMMSI

$1.63B+13.9%

ITG

Integer HoldingsITGR

$1.7B+5.6%

IAR

Integra LifeSciencesIART

$1.04B-31.6%

MiMedx GroupMDXG

$242.94M+19.8%

Other financials

Income statement

See full

Revenue$127.4M+226%

Gross profit$115.4M+207%

Operating income$63.7M+216%

Net income$38.6M+87.0%

EPS (diluted)$0.43+43.3%

Balance sheet

See full

Cash & equivalents$179.1M+170%

Total debt$4.3M+729%

Total assets$815.6M+445%

Cash flow

See full

Operating cash flow$42.4M+115%

CapEx$729.0K+7,190%

Free cash flow$41.7M+111%

Valuation

See full

Market cap$605.65M-34.4%

P/E3.4×—

P/S1.5×-9.6×

Profitability

See full

Gross margin91.9%-3.5pp

Operating margin48.4%—

Net margin45.2%—

FCF margin48.7%+38.8pp

Returns & leverage

See full

Return on equity65.6%—

Debt / equity0×0.0×

Current ratio3×-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CorMedix's total equity?: CorMedix (CRMD) reported total equity of $437.05M in Q1 2026.
How has CorMedix's total equity changed year-over-year?: CorMedix's total equity increased by 280.4% year-over-year, from $114.89M to $437.05M.
What is the long-term trend for CorMedix's total equity?: Over 5 years (2020 to 2025), CorMedix's total equity has grown at a 55.7% compound annual growth rate (CAGR), from $44.22M to $405.31M.
What does total equity mean?: Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.